Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.15
+0.14 (2.00%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4.62 | 6.44 | 29.62 | 46.8 | 140.73 | 235.31 |
Revenue Growth | -37.16% | -78.26% | -36.71% | -66.74% | -40.19% | 33.46% |
Gross Profit Gross Profit Growth | -22.58 | -17.63 | -81.63 | -248.27 | -159.21 | -213.88 |
Operating Income Operating Income Growth | -50.25 | -45.34 | -130.96 | -334.75 | -301.03 | -348.53 |
Net Income Net Income Growth | 183.19 | 183.45 | -47.58 | -284.23 | -293.65 | -290.02 |
Earnings Per Share EPS Growth | 45.27 | 45.38 | -11.89 | -73.03 | -78.45 | -78.51 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | - | 26.11 | 12.96 | 12.52 | 46.12 |
Europe Europe Growth | 5.64 | 6.27 | 9.55 | 33.82 | 131.24 |
Japan Japan Growth | 0.8 | -2.85 | 15.87 | 9.76 | 2.31 |
China China Growth | - | 0.09 | 8.43 | 84.63 | 55.64 |
Total Total Growth | 6.44 | 29.62 | 46.8 | 140.73 | 235.31 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 91.32 | 88.98 | 50.48 | 203.45 | 422.01 | 405.19 |
Total Debt Total Debt Growth | - | 19.56 | 90.1 | 167.48 | 106.98 | 117.35 |
Net Cash (Debt) Net Cash Growth | 91.32 | 69.42 | -39.62 | 35.97 | 315.03 | 287.84 |
Net Cash Growth | - | - | - | -88.58% | 9.45% | -54.17% |
Net Cash Per Share Net Cash Per Share Growth | 22.56 | 17.17 | -9.90 | 9.24 | 84.16 | 77.92 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -38.05 | -4.77 | -138 | -315.02 | -145.93 | -82.23 |
Capital Expenditures CapEx Growth | -0.01 | -0.04 | -0.27 | -2.52 | -3.74 | -5.19 |
Free Cash Flow Free Cash Flow Growth | -38.06 | -4.81 | -138.27 | -317.54 | -149.67 | -87.42 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | -273.80% | -275.59% | - | -113.13% | -90.89% |
Operating Margin | -1088.56% | -704.07% | -442.13% | -715.23% | -213.90% | -148.12% |
Pretax Margin | -669.71% | -905.19% | -517.76% | -690.60% | -208.40% | -123.10% |
Profit Margin | 3968.63% | 2848.63% | -160.63% | -607.29% | -208.66% | -123.25% |
FCF Margin | -824.57% | -74.72% | -466.78% | -678.46% | -106.35% | -37.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 0.16 | 0.19 | - | - | - | - |
Forward PE | - | 201.74 | 201.74 | 201.74 | 201.74 | 201.74 |
PS Ratio | 6.27 | 5.52 | 1.80 | 1.86 | 10.70 | 5.56 |